Safeguard Scientifics, Inc.

Overview

Founded in 1953 and based in Wayne, PA, Safeguard Scientifics, Inc. (NYSE: SFE) provides growth capital for entrepreneurial and innovative life sciences and technology companies. Safeguard targets life sciences companies in Molecular and Point-of-Care Diagnostics, Medical Devices, Regenerative Medicine and Specialty Pharmaceuticals; and technology companies in Internet / New Media, Financial Services IT and Healthcare IT with capital requirements of up to $25 million. Safeguard's status as a publicly-traded company enables us to be a patient partner. We are not subject to the limits of a three-to-five year fundraising cycle (typical with venture capital or buyout firms), enabling us to focus on growing our partner companies' value at an appropriate pace. In addition, gains from sales of partner companies are sheltered from taxes by our net operating losses and are evergreened on our balance sheet, making us self-funding. Our expertise and leadership help accelerate growth, build long-term value and enable business transformation for each of our partner companies.